Tradestie Institutional Equity Comparison Engine

CLSD vs ITRM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-03-31 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ITRM Overall Edge

ITRM Captures Institutional Edge (1โ€“1 Pillars ยท 3โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Iterum Therapeutics plc Ordinary Share (ITRM) driven by superior Growth & Margin while CLSD counters with relative strength in Momentum & Technical. Fundamentally, CLSD trades at N/M Forward P/E with -3502.5% operating margin (-80.6% YoY revenue) versus ITRM at N/M Forward P/E and -1982.3% operating margin (-100.0% YoY). In options structure, CLSD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ITRM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CLSD N/M vs ITRM N/M Fwd P/E
Growth & Margin Winner ITRM
Op Margin -3502.5% vs -1982.3% ยท YoY -80.6% vs -100.0%
Momentum & Technical Winner CLSD
1Y -97.5% vs -97.6% ยท 52W Pos 1% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CLSD NASDAQ
Clearside Biomedical, Inc. Common Stock
Pharmaceutical Preparations
$0.41
-26.96% 1D
Market Cap $2.9M
1M Return -88.86%
1Y Return -97.47%
Forward P/E N/M
Unified AI Score
43.3 / 100 HOLD
Tech 40.0 Fund 43.0 Flow 50.0 Mom 40.0
ITRM NASDAQ
Iterum Therapeutics plc Ordinary Share
Pharmaceutical Preparations
$0.03
-57.39% 1D
Market Cap $3.8M
1M Return -89.38%
1Y Return -97.62%
Forward P/E N/M
Unified AI Score
50.5 / 100 HOLD
Tech 40.0 Fund 52.0 Flow 50.0 Mom 75.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CLSD -97.47% ITRM -97.62% Spread: +33.63 pp (ITRM Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CLSD TTM Op. Margin: -3502.5% ITRM TTM Op. Margin: -1982.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CLSD vs ITRM. Trailing 12-month operating profitability (CLSD -3502.5% vs ITRM -1982.3%) and valuation multiples (CLSD N/M vs ITRM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CLSD (2) vs ITRM (3)
Institutional Metric CLSD ITRM Criterion Row Winner
Market Capitalization Scale $2.9M $3.8M Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -80.6% -100.0% Higher Growth CLSD
Operating Margin (TTM) Profitability -3502.5% -1982.3% Higher Margin ITRM
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -1310.0% -555.7% Higher ROE ITRM
52-Week Range Position Momentum 1% ($0โ€“$17) 0% ($0โ€“$1) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 2.24ฮฒ ยท 269% Vol 1.61ฮฒ ยท 508% Vol Lower Realized Risk CLSD
Unified Institutional Score Composite Signal 43.3 / 100 (HOLD) 50.5 / 100 (HOLD) Higher Composite ITRM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CLSD vs ITRM Buy Guide
CLSD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CLSD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ITRM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ITRM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CLSD nor ITRM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.